SONN•benzinga•
Sonnet BioTherapeutics Prices $5M Public Offering At-The-Market Under Nasdaq Rules, Selling 1.11M Shares And Warrants For Additional 2.22M Shares At $4.50 Per Share
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 6, 2024 by benzinga